Imperva (NASDAQ:IMPV) Cut to “Hold” at Zacks Investment Research

Zacks Investment Research lowered shares of Imperva (NASDAQ:IMPV) from a buy rating to a hold rating in a report issued on Wednesday, January 10th.

According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “

IMPV has been the subject of several other reports. BidaskClub cut Imperva from a hold rating to a sell rating in a research report on Wednesday, December 27th. Morgan Stanley reiterated an underweight rating and set a $39.00 price target on shares of Imperva in a research report on Thursday, November 9th. Wells Fargo & Co cut Imperva from an outperform rating to a market perform rating in a research report on Monday, October 9th. William Blair cut Imperva from an outperform rating to a market perform rating in a research report on Tuesday, October 10th. Finally, Stifel Nicolaus reissued a hold rating and set a $47.00 price objective (down previously from $50.00) on shares of Imperva in a research note on Thursday, November 9th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $51.86.

Shares of Imperva (NASDAQ:IMPV) traded down $0.60 on Wednesday, hitting $43.90. The company had a trading volume of 197,679 shares, compared to its average volume of 337,950. Imperva has a 52-week low of $37.17 and a 52-week high of $52.40. The stock has a market capitalization of $1,490.00, a PE ratio of 162.59 and a beta of 1.78.

Imperva (NASDAQ:IMPV) last issued its quarterly earnings results on Wednesday, November 8th. The software maker reported $0.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.11. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The firm had revenue of $83.89 million during the quarter, compared to analysts’ expectations of $83.79 million. During the same period in the previous year, the business earned $0.08 earnings per share. The firm’s revenue for the quarter was up 22.6% on a year-over-year basis. equities analysts predict that Imperva will post -0.52 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IMPV. Van ECK Associates Corp lifted its stake in shares of Imperva by 0.8% in the 2nd quarter. Van ECK Associates Corp now owns 8,346 shares of the software maker’s stock valued at $399,000 after purchasing an additional 64 shares during the last quarter. Comerica Bank lifted its stake in shares of Imperva by 0.8% in the 2nd quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock valued at $978,000 after purchasing an additional 157 shares during the last quarter. Ameritas Investment Partners Inc. lifted its stake in shares of Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares during the last quarter. Parametric Portfolio Associates LLC lifted its stake in shares of Imperva by 5.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 11,614 shares of the software maker’s stock valued at $556,000 after purchasing an additional 581 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its stake in shares of Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after purchasing an additional 866 shares during the last quarter. 96.93% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This story was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://stocknewstimes.com/2018/01/18/imperva-impv-downgraded-to-hold-at-zacks-investment-research.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply